Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Internal Medicine Physician in Fargo, ND
NPI: 1144370974Primary Employer
Fargo VAMC
va.gov
HQ Phone
Get M.D. Richard's Phone Numberphone_androidMobile
Get M.D. Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NY State Medical License
NY State Medical License
2021 - 2026
CA State Medical License
2003 - 2022
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 2001
Residency • Internal Medicine
2001 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | 84 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 71 | 79 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 66 | 70 |
Health care industries’ perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay
Authors: Tarek Elbeik, Richard A Loftus, Scott Beringer
Publication Date: 2002-05
HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep®/TaqMan® test
Authors: Tarek Elbeik, Ralph Dalessandro, Richard A Loftus, Scott Beringer
Publication Date: 2007-11
Authors: Steven Deeks
Journal: AIDS
Lead Sponsor: CytoDyn, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Leronlimab (700mg)
Lead Sponsor: City of Hope Medical Center
Collaborators: California Institute for Regenerative Medicine (CIRM), Sangamo Therapeutics
Intervention / Treatment: GENETIC: SB-728mR-HSPC Infusion 3 days following busulfan conditioning
Lead Sponsor: TaiMed Biologics Inc.
Collaborators: Westat
Intervention / Treatment: DRUG: Optimized Background Regimen, DRUG: ibalizumab